What is the ticker symbol for SAB Biotherapeutics?

SAB Biotherapeutics trades under the ticker SABS on NASDAQ.

What sector does SAB Biotherapeutics operate in?

SAB Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SABS in a portfolio?

PortView shows SABS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

SAB Biotherapeutics (SABS) Stock Analysis

NASDAQHealthcareBiotechnology

$3.63-1.89%

1-year price historyRange $1.95 – $4.59

52-week range$3.63

$1.85$5.15

What SAB Biotherapeutics does

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Key metrics

Market cap

$330.28M

P/E (TTM)

-2.79

EPS (TTM)

$-1.30

Beta

0.53

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$3.74

200-day avg

$3.81

52-week high

$5.15

52-week low

$1.85

CEO

Samuel J. Reich

ETFs linked to SABS

Broad-market and Healthcare sector ETFs an investor holding SAB Biotherapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SABS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SABS in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for SAB Biotherapeutics?: SAB Biotherapeutics trades under the ticker SABS on NASDAQ.
Which exchange is SABS listed on?: SABS is listed on NASDAQ.
What sector does SAB Biotherapeutics operate in?: SAB Biotherapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SABS in a portfolio?: PortView shows SABS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.